Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Goddard

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Journal of the American Society of Nephrology : JASN|October 7, 2004
Endothelin A receptor antagonism and angiotensin-converting enzyme inhibition are synergistic via an endothelin B receptor-mediated and nitric oxide-dependent mechanismJane Goddard, Corine Eckhart, Neil R Johnston, et al.
British Journal of Clinical Pharmacology|July 20, 2007
The pharmacokinetic profile of sitaxsentan, a selective endothelin receptor antagonist, in varying degrees of renal impairmentNeeraj Dhaun, Vanessa Melville, William Kramer, et al.
Hypertension (Dallas, Tex. : 1979)|August 5, 2009
Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney diseaseNeeraj Dhaun, Iain M Macintyre, Vanessa Melville, et al.
Hypertension (Dallas, Tex. : 1979)|June 10, 2009
Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney diseaseNeeraj Dhaun, Iain M Macintyre, Vanessa Melville, et al.
Journal of the American Society of Nephrology : JASN|December 18, 2012
Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKDNeeraj Dhaun, Vanessa Melville, Scott Blackwell, et al.
Hypertension (Dallas, Tex. : 1979)|March 2, 2011
Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney diseaseNeeraj Dhaun, Iain M MacIntyre, Debbie Kerr, et al.
Circulation|February 26, 2004
Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockadeJane Goddard, Neil R Johnston, Malcolm F Hand, et al.
American Journal of Physiology. Renal Physiology|March 13, 2009
Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritisNeeraj Dhaun, Pajaree Lilitkarntakul, Iain M Macintyre, et al.
Journal of Lipid Research|November 27, 2014
Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney diseaseAna Reis, Alisa Rudnitskaya, Pajaree Chariyavilaskul, et al.
Atherosclerosis|March 8, 2011
Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidityPajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Journal of the American Society of Nephrology : JASN|October 7, 2004
Endothelin A receptor antagonism and angiotensin-converting enzyme inhibition are synergistic via an endothelin B receptor-mediated and nitric oxide-dependent mechanismJane Goddard, Corine Eckhart, Neil R Johnston, et al.
British Journal of Clinical Pharmacology|July 20, 2007
The pharmacokinetic profile of sitaxsentan, a selective endothelin receptor antagonist, in varying degrees of renal impairmentNeeraj Dhaun, Vanessa Melville, William Kramer, et al.
Hypertension (Dallas, Tex. : 1979)|August 5, 2009
Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney diseaseNeeraj Dhaun, Iain M Macintyre, Vanessa Melville, et al.
Hypertension (Dallas, Tex. : 1979)|June 10, 2009
Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney diseaseNeeraj Dhaun, Iain M Macintyre, Vanessa Melville, et al.
Journal of the American Society of Nephrology : JASN|December 18, 2012
Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKDNeeraj Dhaun, Vanessa Melville, Scott Blackwell, et al.
Hypertension (Dallas, Tex. : 1979)|March 2, 2011
Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney diseaseNeeraj Dhaun, Iain M MacIntyre, Debbie Kerr, et al.
Circulation|February 26, 2004
Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockadeJane Goddard, Neil R Johnston, Malcolm F Hand, et al.
American Journal of Physiology. Renal Physiology|March 13, 2009
Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritisNeeraj Dhaun, Pajaree Lilitkarntakul, Iain M Macintyre, et al.
Journal of Lipid Research|November 27, 2014
Top-down lipidomics of low density lipoprotein reveal altered lipid profiles in advanced chronic kidney diseaseAna Reis, Alisa Rudnitskaya, Pajaree Chariyavilaskul, et al.
Atherosclerosis|March 8, 2011
Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidityPajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, et al.
Pageof 4